Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (ChiCTR2500114694) titled 'A multicenter, randomized, blinded (investigator-subject blind), parallel-group controlled clinical trial to evaluate the efficacy and safety of injectable Sodium Hyaluronate Composite Solution in improving skin dryness, dullness, and elasticity in adults' on Dec. 16, 2025.

Study Type: Interventional study

Study Design: Parallel

Primary Sponsor: Department of Dermatology, Beijing Friendship Hospital

Condition: facial rejuvenation

Intervention: Experimental group:Full-face injection of Sodium Hyaluronate Complex Solution produced by Zhu Yan Legend (Xiamen) Biotechnology Co., Ltd.

Recruitment Status: Not Re...